FNF CLO awarded 29,218 restricted shares; direct stake 195,026.988

Fidelity National Financial (FNF) reported an equity award to its EVP, Chief Legal Officer.

Rhea-AI Filing Summary

Fidelity National Financial (FNF) reported an equity award to its EVP, Chief Legal Officer. On 11/10/2025, the officer acquired 29,218 shares of restricted common stock at $0. The award vests in three equal annual installments beginning 11/10/2026, subject to performance criteria in the award agreement.

Following the grant, directly held common stock was 195,026.988 shares. Indirect holdings included 2,606.07 shares in a 401(k) account, 473 shares in an IRA, and 74,898 shares in a trust.

Insights

Corporate governance analyst

Routine insider equity grant with performance-based vesting.

The filing records a grant of 29,218 restricted shares at $0 to FNF’s EVP, Chief Legal Officer. These are performance‑based awards vesting in three equal tranches starting 11/10/2026, aligning compensation with multi‑year results.

Post‑grant direct holdings are 195,026.988 shares, with additional indirect balances in retirement and trust accounts. As a standard compensation action, market impact depends on future vesting and any sales activity disclosed later.

Insider Trade Summary

Grant/Award: 29,218 shares

Grant/Award 4 txns

Insider SADOWSKI PETER T

Role EVP, Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29,218	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 195,026.988 shares (Direct); Common Stock — 2,606.07 shares (Indirect, 401(k) account); Common Stock — 473 shares (Indirect, IRA); Common Stock — 74,898 shares (Indirect, Trust)

Footnotes (1)

1. F1. Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026, subject to the achievement of performance criteria specified in the reporting person's award agreement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did FNF (FNF) disclose in this Form 4?

An executive received 29,218 restricted shares at $0 on 11/10/2025, subject to performance criteria and time-based vesting.

Who received the FNF equity grant and what is their role?

FNF’s EVP, Chief Legal Officer was the reporting person receiving the restricted stock award.

What is the vesting schedule for the FNF award?

The restricted shares vest in three equal annual installments beginning on 11/10/2026, subject to performance criteria.

How many FNF shares does the executive hold after the transaction?

Direct ownership was 195,026.988 shares after the grant; indirect holdings were 2,606.07 (401(k)), 473 (IRA), and 74,898 (trust).

Was the equity grant part of a Rule 10b5-1 plan?

The excerpt includes the 10b5‑1 checkbox language; no plan status is indicated in the provided details.

What type of security was granted by FNF?

Restricted common stock subject to performance criteria, granted at $0.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/13/2025 - 04:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SADOWSKI PETER T

(Last) (First) (Middle)

601 RIVERSIDE AVENUE

(Street)

JACKSONVILLE FL 32204

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fidelity National Financial, Inc. [ FNF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		A		29,218(1)	A	$0	195,026.988	D
Common Stock								2,606.07	I	401(k) account
Common Stock								473	I	IRA
Common Stock								74,898	I	Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026, subject to the achievement of performance criteria specified in the reporting person's award agreement.

	/s/ Colleen E. Haley, as attorney-in-fact	11/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.